The importance of cancer stem cell phenotype in determining the biological function of CELF2 is further underlined by the fact that CELF2 expression is repressed upon exit from stem cell status, promoted by serum or by miR-199a-3p expression, a pro-differentiating miRNA [13]. The gene discussed is CELF2; the disease is cancer.